These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3843510)

  • 1. Mouse liver tumor data: assessment of carcinogenic activity.
    Pereira MA
    Toxicol Ind Health; 1985 Dec; 1(4):311-33. PubMed ID: 3843510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential role of chemically induced hyperplasia in the carcinogenic activity of the hypolipidemic carcinogens.
    Butterworth BE; Loury DJ; Smith-Oliver T; Cattley RC
    Toxicol Ind Health; 1987 Jun; 3(2):129-49. PubMed ID: 3303446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal mouse model: review of methods and results.
    McClain RM; Keller D; Casciano D; Fu P; MacDonald J; Popp J; Sagartz J
    Toxicol Pathol; 2001; 29 Suppl():128-37. PubMed ID: 11695548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nongenotoxic carcinogens: development of detection methods based on mechanisms: a European project.
    Yamasaki H; Ashby J; Bignami M; Jongen W; Linnainmaa K; Newbold RF; Nguyen-Ba G; Parodi S; Rivedal E; Schiffmann D; Simons JW; Vasseur P
    Mutat Res; 1996 Jun; 353(1-2):47-63. PubMed ID: 8692192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments.
    Butterworth BE; Conolly RB; Morgan KT
    Cancer Lett; 1995 Jun; 93(1):129-46. PubMed ID: 7600540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
    Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver tumor promoters and other mouse liver carcinogens.
    Ward JM; Diwan BA; Lubet RA; Henneman JR; Devor DE
    Prog Clin Biol Res; 1990; 331():85-108. PubMed ID: 2179967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anomalous nonidentity between Salmonella genotoxicants and rodent carcinogens: nongenotoxic carcinogens and genotoxic noncarcinogens.
    Yoshikawa K
    Environ Health Perspect; 1996 Jan; 104(1):40-6. PubMed ID: 8834860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Tg rasH2 mouse in cancer hazard identification.
    Morton D; Alden CL; Roth AJ; Usui T
    Toxicol Pathol; 2002; 30(1):139-46. PubMed ID: 11890467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications for risk assessment of suggested nongenotoxic mechanisms of chemical carcinogenesis.
    Melnick RL; Kohn MC; Portier CJ
    Environ Health Perspect; 1996 Mar; 104 Suppl 1(Suppl 1):123-34. PubMed ID: 8722116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chloroform mode of action: implications for cancer risk assessment.
    Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active cell death (apoptosis) and cellular proliferation as indicators of exposure to carcinogens.
    Schulte-Hermann R; Bursch W; Marian B; Grasl-Kraupp B
    IARC Sci Publ; 1999; (146):273-85. PubMed ID: 10353391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis.
    Ashby J; Brady A; Elcombe CR; Elliott BM; Ishmael J; Odum J; Tugwood JD; Kettle S; Purchase IF
    Hum Exp Toxicol; 1994 Nov; 13 Suppl 2():S1-117. PubMed ID: 7857698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of rat liver foci assay and strain A mouse lung tumor assay to detect carcinogens: a review.
    Pereira MA; Stoner GD
    Fundam Appl Toxicol; 1985 Aug; 5(4):688-99. PubMed ID: 3899833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of genotoxic and nongenotoxic effects in multistage carcinogenicity of aromatic amines.
    Neumann HG; Hammerl R; Hillesheim W; Wildschütte M
    Environ Health Perspect; 1990 Aug; 88():207-11. PubMed ID: 2272316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk assessment of nongenotoxic carcinogens based upon cell proliferation/death rates in rodents.
    Gaylor DW; Zheng Q
    Risk Anal; 1996 Apr; 16(2):221-5. PubMed ID: 8638041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative models for carcinogenicity testing: weight of evidence evaluations across models.
    Cohen SM
    Toxicol Pathol; 2001; 29 Suppl():183-90. PubMed ID: 11695556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicology and carcinogenesis studies of o-nitrotoluene sulfone (CAS no. 88-72-2) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program, Public Health Service, National Institutes of Health, US Department of Health and Human Services
    Natl Toxicol Program Tech Rep Ser; 2002 May; (504):1-357. PubMed ID: 12087420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medium-term rat liver bioassay for rapid detection of carcinogens and modifiers of hepatocarcinogenesis.
    Ito N; Hasegawa R; Imaida K; Takahashi S; Shirai T
    Drug Metab Rev; 1994; 26(1-2):431-42. PubMed ID: 8082578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.